This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Analysts' Actions: T, COF, MSFT, LLY, CMG

NEW YORK ( TheStreet) -- CHANGE IN RATINGS, EPS

Accretive Health (AH) upgraded at Goldman from Neutral to Buy. $31 price target. Stock is attractive, following a 38% selloff.

Acme Packet (APKT) numbers reduced at Goldman. Shares of APKT now seen reaching $35, according to Goldman Sachs. Estimates also cut, given slower expected revenue growth. Neutral rating.

Alaska Air (ALK) numbers raised at Citigroup. Shares of ALK now seen reaching $81. Estimates also increased leading fundamentals and attractive valuation. Buy rating.

Alaska Air estimates raised at UBS through 2012. Solid 3Q and 2012 cost guidance positive. Maintain $81 price target and Buy rating.

Alexion Pharmaceuticals (ALXN) numbers upped at Jefferies. ALXN estimates were boosted through 2012. Company is seeing higher Soliris sales and cutting costs. Hold rating and new $58 price target.

Alexion Pharmaceutical estimates, target raised at UBS. Shares of ALXN now seen reaching $70. Estimates also increased on aHUS and margins. Neutral rating.

Alliance Data Systems (ADS) upgraded to buy at TheStreet Ratings.

Altera (ALTR) estimates, target reduced at Jefferies. ALTR estimates were cut through 2012. Inventories are falling. Buy rating and new $43 price target.

Altera estimates, target cut at UBS. Shares of ALTR now seen reaching $44.50. Estimates also lowered as weak macro slows secular growth. Buy rating.

Associated Banc-Corp (ASBC) numbers lowered at Jefferies. Shares of ASBC now seen reaching $11. Estimates also cut, given reduced net interest income expectations. Buy rating.

AT&T (T) estimates lowered at Citigroup through 2012. Reflects an elevation in dilution from a rapid adoption of Smartphones. Maintain $32 price target and Buy rating.

AutoNation (AN) estimates, target raised at Goldman. Shares of AN now seen reaching $34. Estimates also increased, given better realized operating margin. Sell rating.

AutoNation estimates lowered at UBS through 2011. Margins tailwinds end post Q3. Maintain $30 price target and Sell rating.

Baxter (BAX) estimates, target reduced at Goldman. BAX estimates were cut through 2014. Lower sales are hurting margins. Buy rating and new $66 price target.

Blackstone (BX) estimates adjusted at Citigroup through 2012. Reflects the 3Q shortfall, but also stronger long term asset gathering outlook. Maintain $18 price target and Buy rating.

Capital One (COF) numbers increased at Goldman through 2013. Higher revenue is driving margin expansion. Neutral rating and new $51 price target.

1 of 4

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,279.74 +13.75 0.08%
S&P 500 2,010.40 -0.96 -0.05%
NASDAQ 4,579.7890 -13.6380 -0.30%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs